Payers need clear outcomes data to reimburse digital health

The latest stories trending on MedCity News.

Editor's Pick

Top Story Payers Need Clear Outcomes Data to Reimburse Digital Health, Experts Argue It's clear that services like telehealth and remote patient monitoring have potential to provide value within the healthcare industry, but hospitals and digital health companies need to show payers clearer evidence of the outcomes these care modalities can produce in order to earn reimbursement, panelists argued during MedCity's INVEST conference. Sponsored Content MedCity INVEST Speaker Q&A: Thompson Coburn's Daniel Tardiff Presented by MedCity News & Thompson Coburn Healthcare The healthcare lawyer and former GC weighs in on pitfalls for healthcare startups and how executives can find success. Learn More >>

Featured News

Canadian Showcase at MedCity INVEST Champions Healthcare Innovation Presented by the Consulate General of Canada, the Canadian healthcare startup showcase included five companies. Technologies included a patient transfer solution, care coordination, women's health, exercise tracking and remote monitoring for dysphagia, and mental health support. Most Medicaid Enrollees Are Unaware About the Return to Eligibility Renewals The Medicaid continuous enrollment provision ended March 31, meaning states are resuming the renewal process for Medicaid and disenrolling those who no longer qualify for coverage or don't renew coverage. Most Medicaid enrollees are unprepared for this, a survey from the Kaiser Family Foundation showed. Which Healthcare Startups Won the MedCity INVEST Pitch Perfect Contest? The competition saw 23 healthcare startups across biopharma, medical devices, and health tech geared for consumers/employers as well as payers/providers pitch their business plans to teams of investor judges. Health Investors' Benchmarks Have Moved in Current Fundraising Environment, Exec Says Fundraising rounds for health startups are taking longer to close and investors are doing more due diligence, said Ulili Onovakpuri, managing partner of Kapor Capital, during a Monday panel at the MedCity INVEST conference in Chicago. FDA Nod Makes Pfizer's Paxlovid the First Approved Oral Covid-19 Antiviral Drug Paxlovid, a Pfizer antiviral awarded FDA emergency authorization in 2021 for treating Covid-19, is now approved for treating adults. Results from a pivotal clinical showed that Paxlovid led to an 86% reduction in Covid-19-related hospitalization or death from any cause compared to a placebo.

Resources

How AI Helps Health Systems Improve the Quality of Care for Patients with Chronic Conditions Learn how Diagnostic Robotics' AI-powered care management solution helped a regional Blues plan and affiliated hospitals save $1,600 PMPM in cost of care reduction per engaged member by proactively targeting impactable patients and providing optimized care pathways. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe